NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

MaxCyte Inc (OTCGREY: MAXC)

 
MAXC Technical Analysis
5
As on 16th Dec 2021 MAXC STOCK Price closed @ 1.78 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.02 & Strong Sell for SHORT-TERM with Stoploss of 2.20 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MAXCSTOCK Price

Open 1.78 Change Price %
High 1.88 1 Day 0.00 0.00
Low 1.77 1 Week -0.04 -2.20
Close 1.78 1 Month -0.29 -14.01
Volume 350610 1 Year 0.15 9.20
52 Week High 17.00 | 52 Week Low 0.89
 
OTCGREY USA Most Active Stocks
ISVQF 5.45 %
IARED 24.62 %
BLBRF 0.11 %
JRVMF 0.05 %
GCEA 29.00 -21.20%
AHLD 82.75 -2.93%
MAXC 1.78 0.00%
MNSLV 25.50 1.03%
PCOFF 0.16 %
EHITF 613.00 -98.77%
 
OTCGREY USA Top Gainers Stocks
MMCLF 0.63 103.23%
ASTTF 0.04 100.00%
GIGI 2.62 51.45%
JGHAF 35.00 36.99%
GRRMF 103.29 33.42%
GRRMF 103.29 33.42%
MTEI 0.11 33.33%
MTEI 0.11 33.33%
BRYGF 0.17 25.00%
BRYGF 0.17 25.00%
 
OTCGREY USA Top Losers Stocks
BJURF 0.02 -100.00%
BJURF 0.02 -100.00%
EHITF 613.00 -98.77%
EHITF 613.00 -98.77%
SYKWF 0.10 -88.89%
DRVYF 0.01 -75.00%
OISXF 13.80 -67.26%
ALSRF 7.75 -64.77%
ELROF 2.85 -56.36%
NOEJF 13.31 -49.77%
 
 
MAXC
Daily Charts
MAXC
Intraday Charts
Whats New @
Bazaartrend
MAXC
Free Analysis
 
MAXC Important Levels Intraday
RESISTANCE1.99
RESISTANCE1.92
RESISTANCE1.88
RESISTANCE1.84
SUPPORT1.72
SUPPORT1.68
SUPPORT1.64
SUPPORT1.57
 
MAXC Forecast September 2023
4th UP Forecast10.45
3rd UP Forecast7.67
2nd UP Forecast5.95
1st UP Forecast4.23
1st DOWN Forecast-0.67
2nd DOWN Forecast-2.39
3rd DOWN Forecast-4.11
4th DOWN Forecast-6.89
 
MAXC Weekly Forecast
4th UP Forecast1.78
3rd UP Forecast1.78
2nd UP Forecast1.78
1st UP Forecast1.78
1st DOWN Forecast1.78
2nd DOWN Forecast1.78
3rd DOWN Forecast1.78
4th DOWN Forecast1.78
 
MAXC Forecast2023
4th UP Forecast33.67
3rd UP Forecast23.44
2nd UP Forecast17.12
1st UP Forecast10.8
1st DOWN Forecast-7.24
2nd DOWN Forecast-13.56
3rd DOWN Forecast-19.88
4th DOWN Forecast-30.11
 
MaxCyte Inc ( OTCGREY USA Symbol : MAXC )
Sector : N/A And Other Stocks in Same Sector
 
MAXC Other Details
Segment EQ
Market Capital 0.00
Sector
Industry
Offical website >
 
MAXC Address
MAXC
 
MAXC Latest News
 
Your Comments and Response on MaxCyte Inc
 
MAXC Business Profile
MaxCyte, Inc. operates as a cell-based therapies and life sciences company in the United States and internationally. Its transfection systems include MaxCyte STX, a scalable transfection system that uses flow electroporation technology for the engineering of cells for a range of applications; MaxCyte VLX, an instrument for large volume cell-engineering; and MaxCyte GT, a non-viral cell-engineering technology designed for clinical use. The company also provides single use sterile processing assemblies; and proprietary electroporation buffers; and ExPERT brand series of instruments and consumables, as well as insourcing services. In addition, it develops CARMA, a novel and proprietary technology for the development of non-viral, human messenger RNA-based, chimeric antigen receptor or T-cell receptor redirected immune cell therapies. The company licenses and sells its instruments and technology; and sells its products to drug developers and biopharmaceutical companies. It has a clinical and commercial license agreement with Allogene Therapeutics, Inc. The company was founded in 1998 and is headquartered in Gaithersburg, Maryland. Address: 22 Firstfield Road, Gaithersburg, MD, United States, 20878
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service